Hallador Energy downgraded to Neutral at B. Riley on valuation after the stock's recent run-up and ahead of any long-term ...

Ready Capital reported another poor quarter with negative distributable earnings. Click here to find out why RC stock is a ...

The Voya Small Company Fund underperformed its benchmark, the Russell 2000 Index (the Index) on a net asset value basis. Read ...

Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Discover why now isn't the time to ...

LINC's post-earnings drop stems from valuation risks and capex concerns, yet labor shortages and education demand highlight ...

Dynatrace delivered strong Q1 2026 results with 20% revenue growth, robust ARR expansion, and profitability exceeding ...

Teva Pharmaceutical (TEVA) shows resilience with innovative therapies like Austedo & Ajovy, raising growth potential despite past struggles.

Discover key insights from 3D Systems' Q2 2025 earnings call, including cost-saving strategies, revenue trends, and growth focus areas like MedTech & Dental.

APS segment revenue was $507 million, adjusted EBITDA $80 million, and backlog at $1.57 billion, down 10% year-over-year. MTS segment pro forma revenue was $92 million, with adjusted EBITDA of $18 ...

Discover TAT Technologies' Q2 2025 highlights: 18% revenue growth, record 25%+ gross margin, $85M backlog boost.